Home page > Press > Press releases > Archives > Years > 2011

Years

2011

Novagali Pharma : 2010 annual revenue

pdf

2011/02/28

Novagali Pharma receives positive Scientific Advice from the European Medicines Agency for the Phase III clinical trial of Cyclokat® for the treatment of Dry Eye Disease

pdf

2011/01/05

Mutant human embryonic stem cells provide new insight into myotonic dystrophy

pdf

2011/03/31

NOVAGALI PHARMA COMPLETES PATIENTS RECRUITMENT FOR ITS US PHASE II CLINICAL TRIAL OF CATIOPROST®

pdf

2011/04/14

Novagali Pharma Announces Enrollment of the First Patients in a Pivotal Phase III Study of Cyclokat® for Dry Eye Disease

pdf

2011/04/05

IntegraGen Announces Exclusive Licensing Agreement with The John Hopkins University and Massachusetts General Hospital for Autism Gene

pdf

2011/04/11

IntegraGen - Financial results for 2010

pdf

2011/04/08

Novagali Pharma launches Phase II clinical trial with Catioprost

pdf

2010/12/14

Pages : 1 | 2 | 3 | 4 | 5 |>

Download Acrobat Reader

Agenda

[+] Consult the agenda

In order to receive
Genopole^® press releases^®,
please provide your coordinates
to Press Service

Location map

Dowload available documents